Free Trial

Nuveen Asset Management LLC Sells 5,495 Shares of DocuSign, Inc. (NASDAQ:DOCU)

DocuSign logo with Computer and Technology background

Nuveen Asset Management LLC decreased its position in DocuSign, Inc. (NASDAQ:DOCU - Free Report) by 1.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 523,192 shares of the company's stock after selling 5,495 shares during the period. Nuveen Asset Management LLC owned approximately 0.26% of DocuSign worth $47,056,000 at the end of the most recent quarter.

A number of other institutional investors have also bought and sold shares of DOCU. Park Avenue Securities LLC boosted its position in shares of DocuSign by 183.4% during the 4th quarter. Park Avenue Securities LLC now owns 10,558 shares of the company's stock valued at $950,000 after purchasing an additional 6,832 shares in the last quarter. Ritholtz Wealth Management acquired a new position in DocuSign in the fourth quarter valued at approximately $223,000. Merit Financial Group LLC boosted its holdings in shares of DocuSign by 22.1% during the 4th quarter. Merit Financial Group LLC now owns 18,516 shares of the company's stock worth $1,665,000 after buying an additional 3,352 shares in the last quarter. Ameritas Advisory Services LLC grew its position in shares of DocuSign by 2.5% during the 4th quarter. Ameritas Advisory Services LLC now owns 21,043 shares of the company's stock worth $1,893,000 after buying an additional 512 shares during the period. Finally, Aaron Wealth Advisors LLC grew its position in shares of DocuSign by 14.0% during the 4th quarter. Aaron Wealth Advisors LLC now owns 4,940 shares of the company's stock worth $444,000 after buying an additional 606 shares during the period. Institutional investors own 77.64% of the company's stock.

DocuSign Stock Down 2.2%

DOCU stock traded down $1.92 during trading on Friday, reaching $84.61. The stock had a trading volume of 1,338,668 shares, compared to its average volume of 2,758,064. The company has a market capitalization of $17.13 billion, a price-to-earnings ratio of 17.45, a P/E/G ratio of 6.94 and a beta of 1.21. DocuSign, Inc. has a one year low of $48.70 and a one year high of $107.86. The company's 50 day moving average is $81.77 and its two-hundred day moving average is $85.59.

DocuSign (NASDAQ:DOCU - Get Free Report) last announced its earnings results on Thursday, March 13th. The company reported $0.86 earnings per share for the quarter, topping analysts' consensus estimates of $0.84 by $0.02. The firm had revenue of $776.25 million for the quarter, compared to the consensus estimate of $760.94 million. DocuSign had a return on equity of 14.90% and a net margin of 34.73%. The company's revenue was up 9.0% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.76 EPS. As a group, research analysts predict that DocuSign, Inc. will post 1.17 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of research analysts recently issued reports on the stock. Bank of America dropped their target price on shares of DocuSign from $112.00 to $98.00 and set a "neutral" rating on the stock in a research report on Friday, March 14th. Wedbush reissued a "neutral" rating and set a $100.00 price objective on shares of DocuSign in a research report on Friday, March 14th. Wells Fargo & Company reduced their target price on DocuSign from $73.00 to $65.00 and set an "underweight" rating for the company in a research note on Tuesday, April 22nd. JPMorgan Chase & Co. raised DocuSign from an "underweight" rating to a "neutral" rating and upped their price target for the stock from $70.00 to $75.00 in a research note on Monday, March 10th. Finally, JMP Securities reiterated a "market outperform" rating and issued a $124.00 price target on shares of DocuSign in a report on Thursday, April 17th. One equities research analyst has rated the stock with a sell rating, eleven have assigned a hold rating and four have given a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of "Hold" and an average target price of $92.46.

View Our Latest Stock Report on DocuSign

Insider Activity

In other DocuSign news, CFO Blake Jeffrey Grayson sold 16,111 shares of DocuSign stock in a transaction dated Wednesday, March 19th. The shares were sold at an average price of $83.20, for a total value of $1,340,435.20. Following the sale, the chief financial officer now owns 93,960 shares of the company's stock, valued at approximately $7,817,472. The trade was a 14.64% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Teresa Briggs sold 534 shares of the stock in a transaction that occurred on Monday, March 17th. The shares were sold at an average price of $87.41, for a total transaction of $46,676.94. Following the transaction, the director now directly owns 8,270 shares of the company's stock, valued at $722,880.70. This represents a 6.07% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 47,851 shares of company stock valued at $3,912,239 in the last ninety days. 1.01% of the stock is currently owned by insiders.

DocuSign Company Profile

(Free Report)

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.

Further Reading

Institutional Ownership by Quarter for DocuSign (NASDAQ:DOCU)

Should You Invest $1,000 in DocuSign Right Now?

Before you consider DocuSign, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DocuSign wasn't on the list.

While DocuSign currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

ACT FAST! Congress Is POURING Into This Stock
The Hottest AI Stock You Haven’t Bought Yet
This $13 Trillion Energy Breakthrough Will Make Millionaires

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines